1. Molina H, Kinoshita T, Webster CB, Holers VM (1994) Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J Immunol 153:789–795
2. Carter RH, Spycher MO, Ng YC, Hoffman R, Fearon DT (1988) Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol 141:457–463
3. Luxembourg AT, Cooper NR (1994) Modulation of signaling via the B cell antigen receptors by CD21, the receptor for C3dg and EBV. J Immunol 153:4448–4457
4. Whipple EC, Shanahan RS, Ditto AH, Taylor RP, Lindorfer MA (2004) Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in mice. J Immunol 173(4):2297–2306
5. Haas KM, Hasegawa M, Steeber DA, Poe JC, Zabel MD, Bock CB, Karp DR, Briles DE, Weis J, Tedder TF (2002) Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17:713–723